Francesca Pregnolato
Lombardia Informatica (Italy)(IT)Regione Lombardia
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Platelet Disorders and Treatments, Monoclonal and Polyclonal Antibodies Research, Rheumatoid Arthritis Research and Therapies, Renal Diseases and Glomerulopathies
Most-Cited Works
- → Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome(2020)171 cited
- → A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome(2014)139 cited
- → Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons(2020)122 cited
- → Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β 2 ‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome(2015)103 cited
- → Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)(2015)103 cited
- → Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)(2017)99 cited
- → Twelve‐Year Retention Rate of First‐Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real‐Life Data From a Local Registry(2015)97 cited
- → Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome(2016)81 cited
- → Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases(2017)78 cited
- → HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome(2018)76 cited